We've just received notice that our review paper, which summarises the work we have been doing for the last 7 years, is accepted by Frontiers in Thyroid Endocrinology. Its abstract is now available at:
Frontiers in Thyroid Endocrinology
MINI REVIEW ARTICLE
Provisionally accepted The full-text will be published soon (I expect around mid January).
Front. Endocrinol. | doi: 10.3389/fendo.2017.00364
Minireview: Recent Advances in Thyroid Hormone Regulation: Towards a New Paradigm for Optimal Diagnosis and Treatment
Rudolf Hoermann*, John E. Midgley, Rolf Larisch and Johannes W. Dietrich
The whole paper shows a) in control and expression of thyroid activity everyone is an individual - so that mere placement of values in or out of range is not diagnostically helpful or appropriate. b) TSH is unsuitable for monitoring thyroid hormone therapy, especially T4-only. All parameters TSH, FT4 and FT3 must be used in diagnosis c) the response of a person to thyroid dysfunction is unique and needs therefore unique individual treatment and control of treatment modalities. d) all Randomized Clinical Trials attempting to assess i) preferences for combined T4-T3 treatment over T4-only, and ii) those trying to show correlations between suppressed TSH and atrial fibrillation and osteoporosis are as a class wrongly devised and cannot demonstrate satisfactorily the phenomena they are studying. This comes about from a statistical error that all the studies have made in using nonselection in choosing their patient panels. I hope the paper will be strong ammunition for change in the upcoming review of NICE guidelines on thyroid treatment.
It looks beautiful! Thanks so much for the work you do and for being active on the forum, keeping us informed.